Samuel Ethan Cohen

Dr. Samuel Ethan Cohen

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2017 in Gastrointestinal Endoscopy
Verified
Journal Article
Closed access
FMFolasade P. May
Folasade P. May
MRMark W. Reid
Mark W. Reid
SCSamuel Ethan Cohen
Samuel Ethan Cohen
FDFrancis Dailey
Francis Dailey
BSBrennan M.R. Spiegel
Brennan M.R. Spiegel

4 February 2021 in The Journal of Vascular Access
Verified
Journal Article
Closed access
PDF file
PNPooja Nawathe
Pooja Nawathe
RWRobert Wong
Robert Wong
GPGabriel Pollock
Gabriel Pollock
JGJack Green
Jack Green
MKMichael Kissen
Michael Kissen
EZEvan Zahn
Evan Zahn
Background: Pandemics create challenges for medical centers, which call for innovative adaptations to care for patients during the unusually high census, to distribute stress and work hours among providers, to reduce the likelihood of transmission to health care workers, and to maximize resource utilization. Methods: We describe a multidisciplinary vascular access team’s development to improve frontline providers’ workflow by placing central venous and arterial catheters. Herein we describe the development, organization, and processes resulting in the rapid formation and deployment of this team, reporting on notable clinical issues encountered, which might serve as a basis for future quality improvement and investigation. We describe a retrospective, single-center descriptive study in a large, quaternary academic medical center in a major city. The COVID-19 vascular access team included physicians with specialized experience in placing invasive catheters and whose usual clinical schedule had been lessened through deferment of elective cases. The target population included patients with confirmed or suspected COVID-19 in the medical ICU (MICU) needing invasive catheter placement. The line team placed all invasive catheters on patients in the MICU with suspected or confirmed COVID-19. Results and conclusions: Primary data collected were the number and type of catheters placed, time of team member exposure to potentially infected patients, and any complications over the first three weeks. Secondary outcomes pertained to workflow enhancement and quality improvement. 145 invasive catheters were placed on 67 patients. Of these 67 patients, 90% received arterial catheters, 64% central venous catheters, and 25% hemodialysis catheters. None of the central venous catheterizations or hemodialysis catheters were associated with early complications. Arterial line malfunction due to thrombosis was the most frequent complication. Division of labor through specialized expert procedural teams is feasible during a pandemic and offloads frontline providers while potentially conferring safety benefits.

3 August 2021 in Journal of Bronchology & Interventional Pulmonology
Verified
Journal Article
Closed access
SCSamuel Ethan Cohen
Samuel Ethan Cohen
ALAngelena R. Lopez
Angelena R. Lopez
PNPhilip K. Ng
Philip K. Ng
OFOren A. Friedman
Oren A. Friedman
GCGeorge E. Chaux
George E. Chaux
Background: Coronavirus disease 2019 (COVID-19) can lead to hypoxemic respiratory failure resulting in prolonged mechanical ventilation. Typically, tracheostomy is considered in patients who remain ventilator dependent beyond 2 weeks. However, in the setting of this novel respiratory virus, the safety and benefits of tracheostomy are not well-defined. Our aim is to describe our experience with percutaneous tracheostomy in patients with COVID-19. Materials and Methods: This is a single center retrospective descriptive study. We reviewed comorbidities and outcomes in patients with respiratory failure due to COVID-19 who underwent percutaneous tracheostomy at our institution from April 2020 to September 2020. In addition, we provide details of our attempt to minimize aerosolization by using a modified protocol with brief periods of planned apnea. Results: A total of 24 patients underwent percutaneous tracheostomy during the study. The average body mass index was 33.0±10.0. At 30 days posttracheostomy 17 (71%) patients still had the tracheostomy tube and 14 (58%) remained ventilator dependent. There were 3 (13%) who died within 30 days. At the time of data analysis in November 2020, 9 (38%) patients had died and 7 (29%) had been decannulated. None of the providers who participated in the procedure experienced signs or symptoms of COVID-19 infection. Conclusion: Percutaneous tracheostomy in prolonged respiratory failure due to COVID-19 appears to be safe to perform at the bedside for both the patient and health care providers in the appropriate clinical context. Morbid obesity did not limit the ability to perform percutaneous tracheostomy in COVID-19 patients.

8 November 2023 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
SCSamuel Ethan Cohen
Samuel Ethan Cohen
JBJaime Betancourt
Jaime Betancourt
GHGuy W. Soo Hoo
Guy W. Soo Hoo
Background: The confirmation of malignant pleural effusions (MPE) requires an invasive procedure. Diagnosis can be difficult and may require repeated thoracentesis or biopsies. F18Fluorodeoxyglucose-Positron Emission Tomography (FDG-PET) can characterize the extent of malignant involvement in areas of increased uptake. Patterns of uptake in the pleura may be sufficient to obviate the need for further invasive procedures. Methods: This is a retrospective review of patients with confirmed malignancy and suspected MPE. Patients who underwent diagnostic thoracentesis with cytology and contemporaneous FDG-PET were identified for analysis. Some underwent confirmatory pleural biopsy. The uptake pattern on FDG-PET underwent blinded review and was categorized based on the pattern of uptake. Results: One hundred consecutive patients with confirmed malignancy, suspected MPE and corresponding FDG-PET scans were reviewed. MPE was confirmed in 70 patients with positive pleural fluid cytology or tissue pathology. Of the remaining patients, 15 had negative cytopathology, 14 had atypical cells and 1 had reactive cells. Positive uptake on FDG-PET was noted in 76 patients. The concordance of malignant histology and positive FDG-PET occurred in 58 of 76 patients (76%). Combining histologically confirmed MPE with atypical cytology, positive pleural FDG-PET uptake had a positive predictive value of 91% for MPE. An encasement pattern had a 100% PPV for malignancy. Conclusion: Positive FDG-PET pleural uptake represents an excellent method to identify MPE, especially in patients with an encasement pattern. This may eliminate the need for additional invasive procedures in some patients, even when initial pleural cytology is negative.

1 March 2019 in Le Pharmacien Hospitalier et Clinicien
Verified
Journal Article
Closed access
SCSamuel Ethan Cohen
Samuel Ethan Cohen
LGLaurence Gagnaire
Laurence Gagnaire
CCClaire Cordelle
Claire Cordelle
FBFrançoise Berthet
Françoise Berthet

1 March 2023 in Progress in Community Health Partnerships: Research, Education, and Action
Verified
Journal Article
Open access
PDF file
BLBryan Luukinen
Bryan Luukinen
DTDonna Tuccero
Donna Tuccero
MVMadeleine R. Valier
Madeleine R. Valier
SCSamuel Ethan Cohen
Samuel Ethan Cohen
EKEmily Trambert Kylstra
Emily Trambert Kylstra
MSMina Ruth Silberberg
Mina Ruth Silberberg
Problem: Translating research to support practice is becoming a more prominent goal in the scientific community. However, further innovation and research is needed on effective approaches to this endeavor. Purpose: This case study describes an approach that combines the insights of diffusion of innovation theory with the philosophy and practices of community engagement. Key Points: Elements of our approach included staged dissemination, iterative active engagement, multi-pronged and tailored messaging, use of networks, contextualization of study findings, and emergent strategy. Our work proceeded in five stages, from laying the groundwork to deepened partnership. Conclusions: Our experience illustrates the challenges and confirms the benefits of a community engaged, partnered, and non-linear approach to research translation aimed at improving public health.